Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis

NCT02643212 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis

Interventions

DRUG: Rivaroxaban
DRUG: Placebo

Sponsor

David Garcia Cinca

Collaborators

[object Object]